- Home
- HCAT vs SLRN Comparison
HCAT vs SLRN Comparison
Compare HCAT & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCAT
- SLRN
- Stock Information
- Founded
- HCAT 2008
- SLRN 2020
- Country
- HCAT United States
- SLRN United States
- Employees
- HCAT N/A
- SLRN N/A
- Industry
- HCAT Computer Software: Programming Data Processing
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- HCAT Technology
- SLRN Health Care
- Exchange
- HCAT Nasdaq
- SLRN Nasdaq
- Market Cap
- HCAT 334.1M
- SLRN 309.0M
- IPO Year
- HCAT 2019
- SLRN 2023
- Fundamental
- Price
- HCAT $5.68
- SLRN $1.99
- Analyst Decision
- HCAT Buy
- SLRN Hold
- Analyst Count
- HCAT 11
- SLRN 5
- Target Price
- HCAT $10.91
- SLRN $9.60
- AVG Volume (30 Days)
- HCAT 732.9K
- SLRN 1.6M
- Earning Date
- HCAT 02-20-2025
- SLRN 11-13-2024
- Dividend Yield
- HCAT N/A
- SLRN N/A
- EPS Growth
- HCAT N/A
- SLRN N/A
- EPS
- HCAT N/A
- SLRN N/A
- Revenue
- HCAT $302,062,000.00
- SLRN N/A
- Revenue This Year
- HCAT $5.83
- SLRN N/A
- Revenue Next Year
- HCAT $10.50
- SLRN N/A
- P/E Ratio
- HCAT N/A
- SLRN N/A
- Revenue Growth
- HCAT 4.15
- SLRN N/A
- 52 Week Low
- HCAT $5.35
- SLRN $1.91
- 52 Week High
- HCAT $10.99
- SLRN $8.89
- Technical
- Relative Strength Index (RSI)
- HCAT 29.94
- SLRN 27.77
- Support Level
- HCAT $5.35
- SLRN $1.96
- Resistance Level
- HCAT $7.65
- SLRN $2.19
- Average True Range (ATR)
- HCAT 0.47
- SLRN 0.25
- MACD
- HCAT -0.14
- SLRN -0.03
- Stochastic Oscillator
- HCAT 14.35
- SLRN 3.92
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.